Cited 0 times in
Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 금웅섭 | - |
dc.contributor.author | 이창걸 | - |
dc.date.accessioned | 2014-12-19T17:37:59Z | - |
dc.date.available | 2014-12-19T17:37:59Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 2234-1900 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/91776 | - |
dc.description.abstract | Purpose: For recurrent esophageal cancer after primary definitive radiotherapy, no general treatment guidelines are available. We evaluated the toxicities and clinical outcomes of re-irradiation (re-RT) for recurrent esophageal cancer. Materials and Methods: We analyzed 10 patients with recurrent esophageal cancer treated with re-RT after primary definitive radiotherapy. The median time interval between primary radiotherapy and re-RT was 15.6 months (range, 4.8 to 36.4 months). The total dose of primary radiotherapy was a median of 50.4 Gy (range, 50.4 to 63.0 Gy). The total dose of re-RT was a median of 46.5 Gy (range, 44.0 to 50.4 Gy). Results: The median follow-up period was 4.9 months (range, 2.6 to 11.4 months). The tumor response at 3 months after the end of re-RT was complete response (n = 2), partial response (n = 1), stable disease (n = 2), and progressive disease (n = 5). Grade 5 tracheoesophageal fistula developed in three patients. The time interval between primary radiotherapy and re-RT was less than 12 months in two of these three patients. Late toxicities included grade 1 dysphagia (n = 1). Conclusion: Re-RT of recurrent esophageal cancer after primary radiotherapy can cause severe toxicity. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | RADIATION ONCOLOGY JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Radiation Oncology (방사선종양학) | - |
dc.contributor.googleauthor | Kim Young Suk | - |
dc.contributor.googleauthor | Lee Chang Geol | - |
dc.contributor.googleauthor | Kim Kyung Hwan | - |
dc.contributor.googleauthor | Kim Taehyung | - |
dc.contributor.googleauthor | Lee Joohwan | - |
dc.contributor.googleauthor | Cho Yona | - |
dc.contributor.googleauthor | Koom Woong Sub | - |
dc.identifier.doi | 23346537 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00273 | - |
dc.contributor.localId | A03240 | - |
dc.relation.journalcode | J02592 | - |
dc.identifier.eissn | 2234-3164 | - |
dc.identifier.pmid | 23346537 | - |
dc.subject.keyword | Chemotherapy | - |
dc.subject.keyword | Esophageal cancer | - |
dc.subject.keyword | Neoplasm recurrence | - |
dc.subject.keyword | Radiotherapy | - |
dc.subject.keyword | Re-irradiation | - |
dc.subject.keyword | Toxicity | - |
dc.contributor.alternativeName | Koom, Woong Sub | - |
dc.contributor.alternativeName | Lee, Chang Geol | - |
dc.contributor.affiliatedAuthor | Koom, Woong Sub | - |
dc.contributor.affiliatedAuthor | Lee, Chang Geol | - |
dc.citation.volume | 30 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 182 | - |
dc.citation.endPage | 188 | - |
dc.identifier.bibliographicCitation | RADIATION ONCOLOGY JOURNAL, Vol.30(4) : 182-188, 2012 | - |
dc.identifier.rimsid | 31184 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.